718.00p+28.00 (+4.06%)26 Nov 2021, 18:30
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Maxcyte INC Market & Company News

23.11.2021 07:32MXCTPurchase of Common StockRNS
17.11.2021 17:36MXCTExercise of options and PDMR DealingRNS
11.11.2021 07:00MXCTMaxCyte Reports Third Quarter Financial ResultsRNS
03.11.2021 13:00MXCTAppointment of Chairman of the BoardRNS
29.10.2021 17:01MXCTResult of AGMRNS
28.10.2021 15:00MXCTLicense with Nkarta, Inc.RNS
26.10.2021 07:00MXCTNotice of ResultsRNS
06.10.2021 07:00MXCTHoldings in CompanyRNS
01.10.2021 15:49MXCTNotice of AGM and Change of DirectorRNS
01.10.2021 12:36MXCTTotal Voting RightsRNS
17.09.2021 14:35MXCTMaxCyte Set to Join Russell 2000® IndexReach
14.09.2021 07:00MXCTFiling of Form 10-QRNS
14.09.2021 07:00MXCTHalf-year ReportRNS
06.09.2021 17:21MXCTIssue of Equity and Total Voting RightsRNS
02.09.2021 14:26MXCTNotice of ResultsRNS
10.08.2021 07:00MXCTGrant of OptionsRNS
09.08.2021 07:00MXCTLicense with Sana BiotechnologyRNS
05.08.2021 16:05MXCTAmendments to BylawsRNS
03.08.2021 15:51MXCTClosing of OfferingRNS
02.08.2021 07:00MXCTFull Exercise of Over-Allotment OptionRNS
30.07.2021 16:43MXCTSecond Price Monitoring ExtnRNS
30.07.2021 16:36MXCTPrice Monitoring ExtensionRNS
30.07.2021 07:00MXCTPricing of Offering and Approval to List on NasdaqRNS
26.07.2021 11:14MXCTLaunch of Offering and Application to ListRNS
19.07.2021 12:30MXCTTermination of DI facility and transition to CDIRNS
12.07.2021 07:00MXCTS-1 Financial information & Directorate ChangeRNS
12.07.2021 07:00MXCTPublic Filing of Registration Statement with SECRNS
06.07.2021 17:36MXCTResult of Special MeetingRNS
16.06.2021 07:01MXCTPublication of Annual Report and AccountsRNS
16.06.2021 07:00MXCTStockholder Circular and Notice of Special MeetingRNS
15.06.2021 07:00MXCTMaxcyte Appoints Two New Non-Executive DirectorsRNS
02.06.2021 09:18MXCTTotal Voting RightsRNS
25.05.2021 07:00MXCTSigning of Strategic Platform LicenceRNS
14.05.2021 07:00MXCTProposed Dual-Listing on NasdaqRNS
13.05.2021 07:00MXCTConsolidation of Trading LinesRNS
20.04.2021 07:00MXCTFull Year ResultsRNS
15.04.2021 07:00MXCTNotice of Full Year ResultsRNS
01.04.2021 07:00MXCTTotal Voting RightsRNS
11.03.2021 15:01MXCTHolding(s) in CompanyRNS
03.03.2021 07:00MXCTTotal Voting RightsRNS
23.02.2021 07:00MXCTParticipation in Upcoming Investor ConferencesReach
19.02.2021 07:00MXCTDirector Dealings and Issue of EquityRNS
17.02.2021 17:44MXCTGrant of OptionsRNS
15.02.2021 16:32MXCTHolding(s) in CompanyRNS
12.02.2021 13:59MXCTHolding(s) in CompanyRNS
08.02.2021 14:59MXCTHolding(s) in CompanyRNS
05.02.2021 09:01MXCTPrice Monitoring ExtensionRNS
04.02.2021 07:00MXCTDirector Dealings and Issue of EquityRNS
04.02.2021 07:00MXCTCORRECTION: MaxCyte Announces £40m SubscriptionRNS
03.02.2021 16:36MXCTMaxCyte Announces £40 million SubscriptionRNS
03.02.2021 16:35MXCTAppointment of Joint Corporate BrokerRNS
21.01.2021 14:49MXCTIncrease to Block ListingRNS
20.01.2021 07:00MXCTTrading UpdateRNS
11.01.2021 07:00MXCTMyeloid Therapeutics Clinical & Commercial LicenseRNS
Showing 1 to 54 of 54